Kenneth Hallows, MD, Nephrology, Los Angeles, CA, Keck Hospital of USC

KennethRHallowsMDPhD, FASN

Nephrology Los Angeles, CA

Professor of Medicine; Chief, Division of Nephrology and Hypertension; Director, USC/UKRO Kidney Research Center / University of Southern California Keck School of Medicine

Dr. Hallows is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hallows' full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryMedicalSchool
  • Brown UniversityOtherTraining

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2015 - 2021
  • PA State Medical License
    PA State Medical License 1996 - 2016
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Fellow (ASNF) American Society of Nephrology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Design and in vivo characterization of kidney-targeting peptide amphiphile micelles toward renal drug delivery  
    Wang, J., Poon, C., Chin, D., Milkowski, S., Lu, V., Hallows, K.R., and Chung, E.J., Nano Res. 11(10): 5584-5595, 2018.
  • Muc1 is protective during kidney ischemia-reperfusion injury  
    Pastor-Soler, N.M., Sutton, T.A., Mang, H.E., Kinlough, C.L., Gendler, S.J., Madsen, C.S., Bastacky, S., Ho, J., Al-bataineh, M.M., Hallows, K.R., Singh, S., Monga, S...., Am. J. Physiol. Renal Physiol.

Lectures

  • Metabolic Reprogramming in Polycystic Kidney Disease 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Authored Content

  • MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney InjurySeptember 2018

Press Mentions

  • MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney Injury
    MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney Injury
  • World Kidney Day: Keck Medicine of USC Experts Discuss Kidney Health and Research
    World Kidney Day: Keck Medicine of USC Experts Discuss Kidney Health and ResearchMarch 08, 2017

Grant Support

  • Effects of Combination Therapy with Tolvapatan and the Farnesoid X Receptor Agonist INT-747 on Hepatotoxicity, Metabolic and Injury Biomarkers, and Cystogenesis in ADPKDOtsuka Pharmaceuticals, Inc.2019–2020
  • Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease (Clinical Trial Award)U.S. Department of Defense2015–2020
  • Cellular Energy Pathways as Novel Targets for the Therapy of Autosomal Dominant Polycystic Kidney DiseaseU.S. Department of Defense2015–2018
  • Mechanisms and Relevance of Sodium Transport Regulation by AMPKNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2012–2017
  • Mechanisms And Relevance Of ENAC Regulation By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
  • Mechanisms Of ENAC Regulation By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
  • Mechanism Of Inhibition Of CFTR By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
  • Mechanism Of Inhibition Of CFTR By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2001
  • Novel Interaction Of Amp-Kinase With CFTR C1 ChannelNational Institute Of Diabetes And Digestive And Kidney Diseases2000
  • Novel Interaction Of Amp-Kinase With CFTR CL ChannelNational Institute Of Diabetes And Digestive And Kidney Diseases1999

Professional Memberships

Hospital Affiliations